Results
Sudeep Pharma FY26 Revenue Up 28% to ₹642 Cr, Acquires NSS Ireland
Sudeep Pharma reported FY26 consolidated revenue of ₹642.3 Cr, up 28% YoY, with PAT at ₹174.3 Cr and declared final dividend of ₹1.50 per share.
The company completed an IPO raising ₹9,500 Cr and acqu
